| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2014PLoSO...9j4455E |
| P356 | DOI | 10.1371/JOURNAL.PONE.0104455 |
| P932 | PMC publication ID | 4169423 |
| P698 | PubMed publication ID | 25233099 |
| P5875 | ResearchGate publication ID | 265791050 |
| P50 | author | Ahmed Idbaih | Q55459195 |
| Véronique Quillien | Q56561667 | ||
| Philippe Menei | Q56561669 | ||
| Marc Sanson | Q91049282 | ||
| Yannick Marie | Q123501275 | ||
| Jean-Yves Delattre | Q33263302 | ||
| Dominique Figarella-Branger | Q40379595 | ||
| Lucie Karayan-Tapon | Q40380664 | ||
| P2093 | author name string | Jean Mosser | |
| Marie de Tayrac | |||
| Marc Aubry | |||
| Amandine Etcheverry | |||
| Elodie Vauleon | |||
| Rachel Boniface | |||
| P2860 | cites work | IDH1 and IDH2 mutations in gliomas | Q24648948 |
| Comprehensive genomic characterization defines human glioblastoma genes and core pathways | Q24656128 | ||
| Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | Q27860910 | ||
| Diacylglycerol kinase iota regulates Ras guanyl-releasing protein 3 and inhibits Rap1 signaling | Q28588899 | ||
| Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial | Q29547224 | ||
| Malignant gliomas in adults | Q29615708 | ||
| IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype | Q29617457 | ||
| DNA methylation in glioblastoma: impact on gene expression and clinical outcome | Q33771159 | ||
| Age as an independent prognostic factor in patients with glioblastoma: a Radiation Therapy Oncology Group and American College of Surgeons National Cancer Data Base comparison | Q33790042 | ||
| Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, MethyLight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of | Q34251032 | ||
| Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma | Q34584754 | ||
| Can the prognosis of individual patients with glioblastoma be predicted using an online calculator? | Q37021532 | ||
| Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma. | Q37481324 | ||
| Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3. | Q40143844 | ||
| IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas | Q42164790 | ||
| Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion | Q43830464 | ||
| Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers | Q44105023 | ||
| Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. | Q45918451 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chemotherapy | Q974135 |
| glioblastoma | Q282142 | ||
| temozolomide | Q425088 | ||
| P304 | page(s) | e104455 | |
| P577 | publication date | 2014-09-18 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | DGKI methylation status modulates the prognostic value of MGMT in glioblastoma patients treated with combined radio-chemotherapy with temozolomide | |
| P478 | volume | 9 |
| Q38861997 | DNA methylation in adult diffuse gliomas |
| Q53201325 | Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation. |
| Q98178420 | Overexpression of DGKI in Gastric Cancer Predicts Poor Prognosis |
| Q64261069 | Sequential treatment of phenethyl isothiocyanate increases sensitivity of Temozolomide resistant glioblastoma cells by decreasing expression of MGMT via NF-κB pathway |
| Q59807366 | Sulforaphane from Cruciferous Vegetables: Recent Advances to Improve Glioblastoma Treatment |
| Q52606179 | The Clinical Significance of O6-Methylguanine-DNA Methyltransferase Promoter Methylation Status in Adult Patients With Glioblastoma: A Meta-analysis. |
| Q36185826 | The Correlation of MGMT Promoter Methylation and Clinicopathological Features in Gastric Cancer: A Systematic Review and Meta-Analysis |
| Q59793096 | The expression of EMX2 lead to cell cycle arrest in glioblastoma cell line |
Search more.